Methods and compositions for single chain variable region enox2 antibodies for cancer detection and diagnosis
AssigneeMor-NuTech, Inc.
InventorsD. James Morrè, Brandon Eugene Hostetler, James Jinpal Kim
Life of this patent
Estimating the term…
Loading patent…
AssigneeMor-NuTech, Inc.
InventorsD. James Morrè, Brandon Eugene Hostetler, James Jinpal Kim
Estimating the term…
All neoplastic cells express one or more members of a unique family of cell surface ubiquinone (NADH) oxidase proteins with protein disulfide-thiol interchange activity (ECTO-NOX proteins) that are characteristically inhibited by quinone site inhibitors with anti-cancer activity and a common amino acid sequence disclosed herein that allows for cancer-specific antibody recognition as well as for detection of certain critical reference proteins that provide loading controls. Cancers of different cellular or tissue origins express different ENOX2 cancer isoforms or combinations of isoforms and shed these proteins into the circulation. Herein are disclosed methods both for cancer detection and diagnosis of particular origin, based on the patterns and molecular weights of the isoforms which allow the identification of the cell type and or tissue of origin of the neoplasm. Relative ENOX2 amounts are proportional to tumor burden and provide a reliable measure of response to therapy and disease progression. Also provided is the amino acid sequence to which the scFv antibodies bind as the molecular basis for the specificity of the test.
A composition of matter comprising a single chain variable region ENOX2 antibody linked to an alkaline phosphatase or other single step agent for detection or imaging.
An isolated DNA comprising substantially the sequence of SEQ ID NO:
A method for producing a single chain variable region ENOX2 antibody comprising introducing into a cell a DNA sequence as shown in SEQ ID NOS:
An isolated amino acid sequence immediately adjacent to the amino acid sequence providing the critical antigen sequence required for the ENOX2 specific antibody to specifically bind ENOX2 that provides for recognition of two reference proteins a 53 kDa isoelectric point pH 4.1, mostly phosphorylated alpha1 trypsin inhibitor (alpha2-HS-glycoprotein;
A method for detecting cancer comprising detecting isoforms of the ENOX2 protein in comparison with either alpha-antirypsin inhibitor or serrotransferrin reference values.
Dependencies are inferred from the claim text.